Claim: BPC157 is a peptide that is being investigated by the FDA for its effectiveness in treating ulcerative colitis.
Verdict: Unverified (50% confidence)
Explanation: The claim that BPC157 is a peptide being investigated by the FDA for its effectiveness in treating ulcerative colitis is currently unverified. While the FDA Briefing Document indicates that BPC-157 is being evaluated for the treatment of ulcerative colitis, the evidence is dated and does not provide recent confirmation of the current state of the investigation. Additionally, while PubMed supports that BPC-157 is a peptide with potential therapeutic effects for inflammatory bowel disease, this ev...